Genocea Biosciences
E967267
UNEXPLORED
Genocea Biosciences is a biotechnology company that develops T cell–targeted vaccines and immunotherapies using a proprietary antigen discovery platform.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Genocea Biosciences canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T12172975 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Genocea Biosciences Context triple: [David Sinclair, coFounded, Genocea Biosciences]
-
A.
Nautilus Biotechnology
Nautilus Biotechnology is a life sciences company developing next-generation, high-throughput proteomics platforms to enable comprehensive analysis of the human proteome for research and drug discovery.
-
B.
Innogen
Innogen is the original name of Imogen, the virtuous and wronged heroine of William Shakespeare’s play "Cymbeline."
-
C.
Insitro
Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
-
D.
Genex
Genex is an airline that uses Minsk National Airport as a primary base of operations for its flight network.
-
E.
Juno Therapeutics
Juno Therapeutics is a biotechnology company focused on developing cutting-edge immunotherapies, particularly CAR-T cell treatments, for cancer.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Genocea Biosciences Target entity description: Genocea Biosciences is a biotechnology company that develops T cell–targeted vaccines and immunotherapies using a proprietary antigen discovery platform.
-
A.
Nautilus Biotechnology
Nautilus Biotechnology is a life sciences company developing next-generation, high-throughput proteomics platforms to enable comprehensive analysis of the human proteome for research and drug discovery.
-
B.
Innogen
Innogen is the original name of Imogen, the virtuous and wronged heroine of William Shakespeare’s play "Cymbeline."
-
C.
Insitro
Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
-
D.
Genex
Genex is an airline that uses Minsk National Airport as a primary base of operations for its flight network.
-
E.
Juno Therapeutics
Juno Therapeutics is a biotechnology company focused on developing cutting-edge immunotherapies, particularly CAR-T cell treatments, for cancer.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.
subject surface form:
David Sinclair